Grommets may leads to higher proportion of patients who have no AOM recurrences at 6 months… compared with active monitoring (low certainty).
It is very uncertain whether grommets changes total number of AOM recurrences at 6 months post‐randomisation compared with placebo medication (very low certainty).
Grommets showed no clear difference in proportion of patients who have no AOM recurrences at 12 months… compared with active monitoring (low certainty).
Grommets showed no clear difference in total number of AOM recurrences at 6 months post‐randomisation compared with active monitoring (low certainty).
It is very uncertain whether grommets changes proportion of patients who have no AOM recurrences at 6 months… compared with antibiotic prophylaxis (very low certainty).
It is very uncertain whether grommets changes total number of AOM recurrences at 6 months post‐randomisation compared with antibiotic prophylaxis (very low certainty).
It is very uncertain whether grommets changes proportion of patients who have no AOM recurrences at 6 months… compared with placebo medication (very low certainty).